Patients with ≥ 8000 microfilariae / mL blood are at risk of this effect and may benefit from apheresis or initial treatment with albendazole 200 mg orally twice a day for 21 days; the goal is to reduce the microfilarial load to < 8000 / mL before DEC is initiated.